{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=no+prior+authorization&page=2", "query": { "intervention": "no prior authorization", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=no+prior+authorization&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-28T23:51:34.424Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06441955", "title": "Covid-19 Long Haul Preventative and Health Promotion Care Clinical Trial Acceleration Program.", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "COVID-19, Long Haul" ], "interventions": [ { "name": "Ritonavir-Boosted Nirmatrelvir (Paxlovid)", "type": "DRUG" }, { "name": "Physiological Evaluation", "type": "DIAGNOSTIC_TEST" }, { "name": "Moderna COVID-19 Vaccine", "type": "BIOLOGICAL" }, { "name": "Biopsychological", "type": "BEHAVIORAL" }, { "name": "Behavioral (e.g., Psychotherapy, Lifestyle Counseling)", "type": "BEHAVIORAL" }, { "name": "Genetic (including gene transfer, stem cell and recombinant DNA)", "type": "GENETIC" }, { "name": "Multidisciplinary approach", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "DRUG", "DIAGNOSTIC_TEST", "BIOLOGICAL", "BEHAVIORAL", "GENETIC", "COMBINATION_PRODUCT" ], "sponsor": "Well- Konnect Healthcare Services and Research Firm", "sponsor_class": "NETWORK", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 100, "start_date": "2024-03-01", "completion_date": "2030-09-30", "has_results": false, "last_update_posted_date": "2024-11-27", "last_synced_at": "2026-09-28T23:51:34.424Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT06441955" }, { "nct_id": "NCT00621478", "title": "Efficacy and Safety Study Comparing Lorazepam and Diazepam for Children in the Emergency Department With Seizures (Status 2)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Status Epilepticus" ], "interventions": [ { "name": "lorazepam or diazepam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Months", "maximum_age": "18 Years", "sex": "ALL", "summary": "3 Months to 18 Years" }, "enrollment_count": 259, "start_date": "2008-02", "completion_date": "2012-05", "has_results": false, "last_update_posted_date": "2012-12-18", "last_synced_at": "2026-09-28T23:51:34.424Z", "location_count": 12, "location_summary": "Davis, California • Aurora, Colorado • Washington D.C., District of Columbia + 9 more", "locations": [ { "city": "Davis", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT00621478" }, { "nct_id": "NCT04393909", "title": "Improving Safety of Diagnosis and Therapy in the Inpatient Setting", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Delirium", "Confusion", "Mental Status Change", "Back Pain", "Hip Pain Chronic", "Chest Pain", "Asthma", "COPD", "Cellulitis", "Soft Tissue Infections", "Cough", "Deep Vein Thrombosis", "Pulmonary Embolism", "Venous Thromboembolism", "Dyspnea", "Electrolyte Metabolism Abnormal", "Fever", "Failure to Thrive", "Weakness", "Protein-Calorie Malnutrition", "Headache", "Neck Pain", "Hypoxia", "Pneumonia", "Sepsis", "Syncope", "Vomiting", "Diarrhea", "Leg Pain", "Abdominal Pain" ], "interventions": [ { "name": "Diagnostic Uncertainty Educational Curriculum", "type": "BEHAVIORAL" }, { "name": "Diagnostic Timeout", "type": "BEHAVIORAL" }, { "name": "Patient Diagnostic (Dx) Questionnaire", "type": "BEHAVIORAL" }, { "name": "Enhancements to Epic-integrated Quality & Safety Dashboard", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 700, "start_date": "2019-07-01", "completion_date": "2021-12-30", "has_results": false, "last_update_posted_date": "2022-07-26", "last_synced_at": "2026-09-28T23:51:34.424Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04393909" }, { "nct_id": "NCT03464396", "title": "Prematurity-Related Ventilatory Control", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Respiratory Control in Premature Infants" ], "interventions": [ { "name": "Bedside Physiology study", "type": "OTHER" }, { "name": "Carotid Body Function Test", "type": "OTHER" }, { "name": "Room Air Challenge", "type": "OTHER" }, { "name": "Hypoxia Challenge Test", "type": "OTHER" }, { "name": "Effects of Nasal Cannula Flow", "type": "OTHER" }, { "name": "Magnetic Resonance Imaging", "type": "DIAGNOSTIC_TEST" }, { "name": "Echocardiogram", "type": "DIAGNOSTIC_TEST" }, { "name": "Blood Sample", "type": "OTHER" } ], "intervention_types": [ "OTHER", "DIAGNOSTIC_TEST" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Day", "maximum_age": "28 Days", "sex": "ALL", "summary": "1 Day to 28 Days" }, "enrollment_count": 177, "start_date": "2018-05-14", "completion_date": "2022-03-09", "has_results": false, "last_update_posted_date": "2023-01-31", "last_synced_at": "2026-09-28T23:51:34.424Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT03464396" }, { "nct_id": "NCT01280747", "title": "Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND Study", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Fibromyalgia", "Painful Diabetic Peripheral Neuropathy" ], "interventions": [ { "name": "prior authorization", "type": "OTHER" }, { "name": "no prior authorization", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 42, "start_date": "2011-01", "completion_date": "2012-04", "has_results": false, "last_update_posted_date": "2021-01-26", "last_synced_at": "2026-09-28T23:51:34.424Z", "location_count": 17, "location_summary": "Beverly Hills, California • Lomita, California • Orange, California + 14 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Lomita", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Santa Maria", "state": "California" }, { "city": "Tulare", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01280747" }, { "nct_id": "NCT04783428", "title": "Tumor-induced Osteomalacia Disease Monitoring Program", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Tumor-induced Osteomalacia (TIO)" ], "interventions": [ { "name": "No intervention", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Ultragenyx Pharmaceutical Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 23, "start_date": "2022-01-31", "completion_date": "2032-02-28", "has_results": false, "last_update_posted_date": "2026-06-03", "last_synced_at": "2026-09-28T23:51:34.424Z", "location_count": 5, "location_summary": "New Haven, Connecticut • Bloomington, Indiana • Baltimore, Maryland + 2 more", "locations": [ { "city": "New Haven", "state": "Connecticut" }, { "city": "Bloomington", "state": "Indiana" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Nashville", "state": "Tennessee" }, { "city": "Charlottesville", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04783428" }, { "nct_id": "NCT01904188", "title": "Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Sepsis", "Systemic Inflammatory Response Syndrome", "Infection Mixed", "Infection, Bacterial", "Infection, Fungal", "Infection, Coronavirus", "Antibiotic Resistance Genes", "Human Genome Analysis" ], "interventions": [ { "name": "Gene Z or other rapid diagnostic techniques developed in our lab (as of 2018 not using Gene Z - now using In-Dx along with other developed techniquesregularly)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Michigan State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2500, "start_date": "2015-06", "completion_date": "2032-07", "has_results": false, "last_update_posted_date": "2026-06-08", "last_synced_at": "2026-09-28T23:51:34.424Z", "location_count": 2, "location_summary": "Lansing, Michigan", "locations": [ { "city": "Lansing", "state": "Michigan" }, { "city": "Lansing", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT01904188" }, { "nct_id": "NCT00943813", "title": "Assessment of Comskil Training Through Videorecording and Patient Surveys", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Comskil Training" ], "interventions": [ { "name": "video-recording and completing a survey", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "ALL", "summary": "19 Years and older" }, "enrollment_count": 55, "start_date": "2009-05", "completion_date": "2016-08", "has_results": false, "last_update_posted_date": "2016-08-16", "last_synced_at": "2026-09-28T23:51:34.424Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00943813" }, { "nct_id": "NCT03987503", "title": "The No One Waits Study: Acceptability and Feasibility of Community-based Point-of-diagnosis HCV Treatment Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hepatitis C, Chronic" ], "interventions": [ { "name": "Epclusa (SOF/VEL)", "type": "DRUG" }, { "name": "Standard of care", "type": "DRUG" }, { "name": "Fibroscan® 430 Mini Plus", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 87, "start_date": "2020-07-01", "completion_date": "2022-12-29", "has_results": true, "last_update_posted_date": "2025-05-28", "last_synced_at": "2026-09-28T23:51:34.424Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03987503" }, { "nct_id": "NCT01570036", "title": "Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "Herceptin", "type": "DRUG" }, { "name": "NeuVax vaccine", "type": "DRUG" }, { "name": "GM-CSF", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "George E. Peoples", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 275, "start_date": "2013-05-21", "completion_date": "2018-09-28", "has_results": true, "last_update_posted_date": "2020-12-02", "last_synced_at": "2026-09-28T23:51:34.424Z", "location_count": 29, "location_summary": "Beverly Hills, California • Santa Monica, California • Santa Rosa, California + 22 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Santa Rosa", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01570036" } ] }